Conference on Biobanking Americas

Venue: Boston USA

Location: Boston, United States

Event Date/Time: Nov 09, 2010 End Date/Time: Nov 11, 2010
Report as Spam


Conference on Biobanking Americas ( Conference and Workshop Only )
The future for next generation drug discovery and personalised medicines
To be held at 9th - 11th November 2010, Boston, USA

Key Speakers
• Dr. Marc Allard, Research Microbiologist, Center for Food Safety and Applied Nutrition, FDA
• Dr. Adel Laoui, Director, Healthcare Technologies Aging Therapeutic Strategic Unit, Sanofi-aventis
• Brenda Yanak, West Point IT Site Head and Account Manager, Franchise Biology, siRNA, Imaging, and GeM, Merck
• Jeff Milton, Bioinformatics & Computational Biology, Genentech
• Dr. John G. Baust, UNESCO Chair & Professor, Director, Institute of Biomedical Technology, State University of New York
• Elaine W. Gunter, Founder and President, Specimen Solutions, LLC, National Cancer Institute
• Dr. Hartmut Juhl, CEO, Indivumed
• James Eliason, Director, Stem Cell Commercialization Center
• Dr. Michael Hehenberger, Business Development Executive, Life Sciences, IBM Thomas J. Watson Research Center
• Kristen Rosati, Partner, Coppersmith Schermer & Brockelman
• Dr. Richard J. Maguire, Director of Business Development – LIMS, Ocimum

An estimated $1bn has been invested in the biobanking industry within the last ten years. At least 179 biobanks with 345,000 donors exist in the US, most of which were established in the last 10 years. (Source: Business Insights, March 2009)

TIME Magazine highlighted biobanking as one of "10 Ideas Changing the World Right Now." Biobanking is rapidly growing and thriving to change approaches to target-finding, drug development and patient treatment. It is being viewed as a key driver for next generation biomarker and drug discovery.

The substantial advancement of research on the human genome has led to the creation of biobanks, which has brought a paradigm shift in drug testing and development. Recognizing the potential benefits from biobanks, pharma and biotech across the world are investing in infrastructure and biobank development.

Reasons to register today:
• Learn how to develop the best practices to leverage biospecimen resources
• Analyse major challenges for biorepository management and implementation
• Get the latest updates on the applications on genome sequencing
• Investigate the future of biobanks, regulation, ethics, investment and the humanization of drug discovery in the Americas
• Determine how to implement virtual biorepository
• Understand the importance of quality management in biobanking
• Gain an insight into the bioprospecting of tissues, DNA, protein or genetic information
• Enable confident decision making by benchmarking yourself against other leaders in the field

Who should attend?

VPs, Directors, Heads, Managers of:
• Biobank
• Tissue bank
• Biorepository/BioSample
• Molecular Diagnostics
• Clinical Genetics, Pathology
• Genomics
• Privacy/Protection/Security
• Scientific and Quality
• Laboratory and Inventory
• R&D
• Quality Control
• Strategic Outsourcing
• Clinical Research
• Translational Medicine
• Personalized Medicine
• Bioanalytical Chemistry
• Pharmacogenomics
• Proteomics
• Business development
• Strategic alliances

Consultants& Academics
Regulatory bodies
Biorepository Vendors
Government Officials